By Caleb Hellerman
CNN’s Dr. Sanjay Gupta reports on MAPS' research on MDMA-assisted psychotherapy as a PTSD treatment, featuring interviews with researchers, participants, and military experts. A three part-series was also published on CNN.com.
By Conor Duffy
The Australian Broadcasting Company looks into a potential opening for new research in Australia into treating PTSD with MDMA-assisted psychotherapy. The article features anecdotes from Steve McDonald of Psychedelic Research in Science & Medicine (PRISM), Rick Doblin of MAPS, and Tony Macie, a study participant from MAPS’ U.S. research. Macie is interviewed about his experience receiving MDMA-assisted psychotherapy as a treatment for PTSD, remarking “If anything, immediately after I did it, I wished it would be allowed for a lot of veterans with PTSD. I think it could make beyond a huge impact.”
By Michael Mithoefer, M.D.
The effects of MDMA appear to increase the likelihood that participants will be able to maintain enough trust in the therapists and a broad enough perspective about their own inner experience to process their fears without emotionally or physically withdrawing from the therapeutic alliance.
MDMA-assisted psychotherapy helps more successfully with PTSD treatment—both through initial reduction of symptoms and through maintenance of that reduction over the long term—than any other form of treatment.
By Jessica Winter
We're talking about the brain, the nervous system, how we make and remake memories, freedom of will—consciousness itself.
By Marcela Ot'alora G., M.A., L.P.C.
After working with trauma for many years, I observed that one of the greatest challenges for people with PTSD is their distorted sense of self. Repeated exposure to painful memories reinforces the individual’s sense that he or she is a victim, and the corresponding experience of guilt and shame produces additional feelings of unworthiness. MDMA-assisted psychotherapy offers a new perspective for working with these destructive symptoms.
By Tom Shroder for the The Washington Post Magazine
Before becoming the first patient treated in the flagship MDMA-assisted psychotherapy study sponsored by MAPS, Donna Kilgore had suffered from PTSD for over 10 years. Donna had been the victim of a brutal rape in her home in 1994.
“It was what it must feel like to have no soul,” she says. She followed a regimen of various antidepressants and tried dozens of different therapists and forms of therapies, but nothing worked. “I was getting to the point where it was either go sit on a mountaintop or go dive off a cliff.” That all changed when she received MDMA-assisted psychotherapy.